EMA Calls For Zinbryta's ‘Immediate’ Suspension After More Reports of Brain Disorders

 
• By Ian Schofield
The EMA has recommended suspending and recalling Zinbryta after 12 reports of serious brain disorders

More from Drug Safety

More from Pink Sheet